On anti-inflammatory and antipyretic mechanism of combination drug employed for the treatment of bronchopulmonary abnormalities

dc.contributor.authorZvyagintseva, T.
dc.contributor.authorKirichek, Lyudmila
dc.contributor.authorMironchenko, Svetlana
dc.contributor.authorKryvoshapka, Oleksandr
dc.contributor.authorStorozhenko, E.
dc.date.accessioned2015-06-04T07:51:27Z
dc.date.available2015-06-04T07:51:27Z
dc.date.issued2015
dc.description.abstractThe study on 30 rats experimentally established the mechanism of anti-inflammatory and antipyretic action of amkesol. These effects depend on polytropic pharmacodynamics of the drug and are associated with restoration of oxidative balance and pro-inflammatory serum cytokine profile, impaired in bronchoalveolitis model.uk_UA
dc.identifier.citationOn anti-inflammatory and antipyretic mechanism of combination drug employed for the treatment of bronchopulmonary abnormalities / T. V. Zvyagintseva, L. T. Kirichek, S. I. Mironchenko, A. V. Krivoschapka, E. V. Storozhenko // Inter Collegas. – 2015. – Vol. 2, № 2. – Р. 140–145.uk_UA
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/9277
dc.language.isoenuk_UA
dc.subjectcombination druguk_UA
dc.subjectmechanism of actionuk_UA
dc.subjectantipyretic and anti-inflammatory effectsuk_UA
dc.subjectbroncho-pulmonary pathologyuk_UA
dc.titleOn anti-inflammatory and antipyretic mechanism of combination drug employed for the treatment of bronchopulmonary abnormalitiesuk_UA
dc.title.alternativeК механизму противовоспалительного и жаропонижающего действия комбинированного препарата для лечения бронхо-легочной патологиuk_UA
dc.title.alternativeДо механізму протизапальної і жарознижувальної дії комбінованого препарату для лікування бронхо-легеневої патологіїuk_UA
dc.typeArticleuk_UA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
61-235-1-PB.pdf
Size:
281.13 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
6.52 KB
Format:
Item-specific license agreed upon to submission
Description: